Literature DB >> 19301008

Whole-body MRI: a helpful diagnostic tool for juvenile dermatomyositis case report and review of the literature.

Nikolay Tzaribachev1, C Well, J Schedel, M Horger.   

Abstract

Juvenile Dermatomyositis (JDM) is a rare autoimmune disease in childhood. Distinction between muscle inflammation and a residual state can be difficult especially under immunosuppressive therapy and in active disease without correlating muscle enzyme tests or functional muscle scores. Our goal is to demonstrate the benefit of whole-body magnetic resonance imaging (MRI) as a diagnostic modality in the detection and management of JDM. One patient with JDM was monitored using clinical examination, muscle enzyme tests, muscle scores and whole-body MRI. During immunosuppression, the patient presented several times to our department without clear correlation between clinical picture, muscle enzyme tests and muscle scores. Whole-body MRI proved reliable in assessing the true state of the disease, thus providing invaluable information in the management of the inflammatory myopathy. This is of utmost importance for the therapeutic optimization in order to prevent further damage especially in children with active but subclinical disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19301008     DOI: 10.1007/s00296-009-0890-y

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  12 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

2.  Acute oedematous dermatomyositis.

Authors:  A E Smyth; A L Bell; M Crone
Journal:  Ann Rheum Dis       Date:  2000-07       Impact factor: 19.103

Review 3.  MRI in inflammatory myopathies.

Authors:  J Garcia
Journal:  Skeletal Radiol       Date:  2000-08       Impact factor: 2.199

4.  The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)--clinical characteristics of children recruited within the first 5 yr.

Authors:  L J McCann; A D Juggins; S M Maillard; L R Wedderburn; J E Davidson; K J Murray; C A Pilkington
Journal:  Rheumatology (Oxford)       Date:  2006-03-27       Impact factor: 7.580

5.  Magnetic resonance imaging appearance of the muscles in childhood dermatomyositis.

Authors:  R J Hernandez; D R Keim; D B Sullivan; T L Chenevert; W Martel
Journal:  J Pediatr       Date:  1990-10       Impact factor: 4.406

6.  Incidence of polymyositis-dermatomyositis: a 20-year study of hospital diagnosed cases in Allegheny County, PA 1963-1982.

Authors:  C V Oddis; C G Conte; V D Steen; T A Medsger
Journal:  J Rheumatol       Date:  1990-10       Impact factor: 4.666

7.  The incidence of juvenile dermatomyositis: results from a nation-wide study.

Authors:  D P Symmons; J A Sills; S M Davis
Journal:  Br J Rheumatol       Date:  1995-08

8.  MRI-guided biopsy in inflammatory myopathy: initial results.

Authors:  A M Pitt; J L Fleckenstein; R G Greenlee; D K Burns; W W Bryan; R Haller
Journal:  Magn Reson Imaging       Date:  1993       Impact factor: 2.546

9.  MR imaging in children with dermatomyositis: musculoskeletal findings and correlation with clinical and laboratory findings.

Authors:  R J Hernandez; D B Sullivan; T L Chenevert; D R Keim
Journal:  AJR Am J Roentgenol       Date:  1993-08       Impact factor: 3.959

10.  Juvenile dermatomyositis at diagnosis: clinical characteristics of 79 children.

Authors:  L M Pachman; J R Hayford; A Chung; C A Daugherty; M A Pallansch; C W Fink; H L Gewanter; R Jerath; B A Lang; J Sinacore; I S Szer; A R Dyer; M C Hochberg
Journal:  J Rheumatol       Date:  1998-06       Impact factor: 4.666

View more
  8 in total

Review 1.  Update on the assessment of children with juvenile idiopathic inflammatory myopathy.

Authors:  Adam M Huber
Journal:  Curr Rheumatol Rep       Date:  2010-06       Impact factor: 4.592

2.  Role of bone scan in the assessment of polymyositis/dermatomyositis.

Authors:  Young-Sil An; Chang-Hee Suh; Ju-Yang Jung; Hyoun-Ah Kim
Journal:  Clin Rheumatol       Date:  2014-12-12       Impact factor: 2.980

3.  Muscle MRI in patients with long-chain fatty acid oxidation disorders.

Authors:  Eugene F Diekman; W Ludo van der Pol; Rutger A J Nievelstein; Sander M Houten; Frits A Wijburg; Gepke Visser
Journal:  J Inherit Metab Dis       Date:  2013-12-05       Impact factor: 4.982

4.  Dermatomyositis Leading to Necrotizing Vasculitis: A Perfect Response to Applied Therapy.

Authors:  Mahmood Akbaryan; Farideh Darabi; Zahra Soltani
Journal:  Int J Biomed Sci       Date:  2016-12

5.  Dexmedetomidine versus propofol on the sedation of pediatric patients during magnetic resonance imaging (MRI) scanning: a meta-analysis of current studies.

Authors:  Qiang Zhou; Lingli Shen; Xinxian Zhang; Jiong Li; Yong Tang
Journal:  Oncotarget       Date:  2017-11-01

Review 6.  The Role of Quantitative and Semi-quantitative [18F]FDG-PET/CT Indices for Evaluating Disease Activity and Management of Patients With Dermatomyositis and Polymyositis.

Authors:  Halil Yildiz; Philippe D'abadie; Olivier Gheysens
Journal:  Front Med (Lausanne)       Date:  2022-04-15

7.  Pervasive inflammatory activation in patients with deficiency in very-long-chain acyl-coA dehydrogenase (VLCADD).

Authors:  Abbe N Vallejo; Henry J Mroczkowski; Joshua J Michel; Michael Woolford; Harry C Blair; Patricia Griffin; Elizabeth McCracken; Stephanie J Mihalik; Miguel Reyes-Mugica; Jerry Vockley
Journal:  Clin Transl Immunology       Date:  2021-06-27

8.  MRI guided wire localization muscle biopsy in a child with juvenile dermatomyositis.

Authors:  Victoria C Tuen; Shannon N Zingula; Christopher Moir; Ann M Reed; Jane M Matsumoto; David A Woodrum
Journal:  Pediatr Rheumatol Online J       Date:  2013-04-08       Impact factor: 3.054

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.